CD47 - an overview | ScienceDirect Topics
CD47 | Majeti Lab | Stanford Medicine
2021 Jeffrey M. Hoeg Award Lecture: Defining the Role of Efferocytosis in Cardiovascular Disease: A Focus on the CD47 (Cluster of Differentiation 47) Axis | Arteriosclerosis, Thrombosis, and Vascular Biology
Localized CD47 blockade enhances immunotherapy for murine melanoma | PNAS
Targeting CD47/TNFAIP8 by miR-155 overcomes drug resistance and inhibits tumor growth through induction of phagocytosis and apoptosis in multiple myeloma | Haematologica
The Antitumor Activities of Anti-CD47 Antibodies Require Fc-FcγR interactions | bioRxiv
Targeting CD47 for cancer immunotherapy | Journal of Hematology & Oncology | Full Text
Cells | Free Full-Text | Targeting the CD47-SIRPα Axis: Present Therapies and the Future for Cutaneous T-cell Lymphoma
JCI - Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47
Antiphagocytic function of CD47 on red blood cells (RBCs). Young RBCs... | Download Scientific Diagram
CD47 and thrombospondin-1 regulation of mitochondria, metabolism, and diabetes | American Journal of Physiology-Cell Physiology
CD47: role in the immune system and application to cancer therapy | Cellular Oncology
CD47: role in the immune system and application to cancer therapy | Cellular Oncology
Regulation of CD47 expression in cancer cells - ScienceDirect
Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells | Nature Communications
CD47‐signal regulatory protein α signaling system and its application to cancer immunotherapy - Murata - 2018 - Cancer Science - Wiley Online Library
Second “Don't Eat Me” Signal Identified in Cancer Cells, Points to New Immunotherapies | The Stem Cellar
CD47/SIRPα pathway mediates cancer immune escape and immunotherapy
CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis | Nature
CD47/SIRP alpha biochemical HTRF binding assay | Cisbio
063CE: Anti-CD47 Testing Interference with Connie Westhoff -
SIRPα–CD47 Immune Checkpoint Blockade in Anticancer Therapy: Trends in Immunology
A) CD47-SIRPɑ interaction blocks macrophage phagocytosis of cancer... | Download Scientific Diagram
Vaccines | Free Full-Text | Anti-CD47 Monoclonal Antibody–Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers
Frontiers | Targeting CD47 as a Novel Immunotherapy for Breast Cancer
